Melody Harris - 11 May 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: Chf Ops Off, Pres, Informatics
Signature: /s/ Ali Olivo, Attorney-in-Fact
Issuer symbol: NEO
Transactions as of: 11 May 2024
Net transactions value: -$25,589
Form type: 4
Filing time: 14 May 2024, 21:38:09 UTC
Previous filing: 03 May 2024
Next filing: 03 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Options Exercise	$0	+7,068	+6.9%	$0.000000	110,023	11 May 2024	Direct	F1
transaction	NEO	Common Stock	Tax liability	$25,589	-1,722	-1.6%	$14.86	108,301	11 May 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEO	Restricted Stock Unit	Options Exercise	$0	-7,068	-33%	$0.000000	14,136	11 May 2024	Common Stock	7,068	$0.000000	Direct	F3, F4
holding	NEO	Stock Option (Right to Buy)						201,613	11 May 2024	Common Stock	201,613	$9.24	Direct	F5
holding	NEO	Stock Option (Right to Buy)						39,683	11 May 2024	Common Stock	39,683	$19.65	Direct	F6
holding	NEO	Performance Stock Unit						21,204	11 May 2024	Common Stock	21,204	$0.000000	Direct	F4, F7
holding	NEO	Stock Option (Right to Buy)						42,344	11 May 2024	Common Stock	42,344	$16.45	Direct	F8
holding	NEO	Restricted Stock Unit						25,329	11 May 2024	Common Stock	25,329	$0.000000	Direct	F4, F9
holding	NEO	Performance Stock Unit						25,330	11 May 2024	Common Stock	25,330	$0.000000	Direct	F4, F10
holding	NEO	Stock Option (Right to Buy)						19,984	11 May 2024	Common Stock	19,984	$13.96	Direct	F11
holding	NEO	Performance Stock Unit						11,939	11 May 2024	Common Stock	11,939	$0.000000	Direct	F4, F12
holding	NEO	Restricted Stock Unit						11,939	11 May 2024	Common Stock	11,939	$0.000000	Direct	F4, F13

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
F2	Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
F3	On May 11, 2023, Ms. Harris was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F4	Once vested, the shares of common stock are not subject to expiration.
F5	On January 1, 2023, Ms. Harris was granted 201,613 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F6	On May 11, 2023, Ms. Harris was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F7	On May 11, 2023, Ms. Harris was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
F8	On February 23, 2024, Ms. Harris was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F9	On February 23, 2024, Ms. Harris was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F10	On February 23, 2024, Ms. Harris was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
F11	On May 2, 2024, Ms. Harris was granted 19,984 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F12	On May 2, 2024, Ms. Harris was granted 11,939 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 17,909. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
F13	On May 2, 2024, Ms. Harris was granted 11,939 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.